No confirmed CDC, FDA, or HHS policy action headline was available in the provided results

The Centers for Disease Control and Prevention updated its interim guidance in 2024 for managing healthcare personnel exposed to SARS-CoV-2, stating that most asymptomatic workers with higher-risk exposures do not require work restrictions. According to CDC officials, this approach relies on serial viral testing and considers work restrictions only in specific situations such as immunocompromise or inability to adhere to infection control measures.

This testing schedule typically occurs on days 1, 3, and 5, with the day of exposure designated as day 0, according to the agency’s “Interim Guidance for Managing Healthcare Personnel with SARS-CoV-2 Infection or Exposure to SARS-CoV-2.” The guidance defines higher-risk exposure as being within six feet of a confirmed infected person or having unprotected direct contact with infectious secretions or excretions.

The CDC’s interim guidance outlines a testing regimen for healthcare personnel exposed to SARS-CoV-2, recommending serial viral testing immediately after exposure, but not earlier than 24 hours, followed by subsequent tests 48 hours apart.

Work restrictions are generally not required for asymptomatic healthcare workers following such exposures, except in specific circumstances. The CDC advises considering work restrictions for personnel who cannot undergo testing or wear source control for 10 days, those who are moderately to severely immunocompromised, healthcare workers caring for highly immunocompromised patients, or those working in units experiencing uncontrolled SARS-CoV-2 transmission, according to CDC officials. The guidance also notes that vaccination status does not alter the recommendation against routine work restrictions for asymptomatic exposed personnel.

The CDC’s webpage states that the interim guidance is subject to revision and references forthcoming updates to the “Guideline for Infection Control in Healthcare Personnel, 1998.” A draft of these updated recommendations is expected to be published in the Federal Register in the coming months, agency officials said.

In related public health developments, a federal judge ordered the restoration of multiple federal health websites and datasets on February 11, 2025, following their abrupt removal in late January. The order covered materials from the Department of Health and Human Services, the Food and Drug Administration, and the CDC, including information on HIV testing and prevention, contraceptive guidance, and vulnerability data related to natural disasters and emergencies. The government was required to restore the cited webpages by midnight Tuesday and identify additional physician resources by the end of that week, according to NPR reporting.

Meanwhile, the Department of Health and Human Services announced a significant workforce restructuring on March 27, 2025, which will reduce its staff by approximately 20,000 positions. The plan involves consolidating 28 divisions into 15 and is expected to cut about 3,500 FDA employees, 2,400 CDC employees, 300 Centers for Medicare & Medicaid Services staff, and 1,200 National Institutes of Health workers, according to a summary by law firm Polsinelli. The reduction includes roughly 10,000 direct job cuts and an additional 10,000 through buyouts or voluntary resignations, aiming to return HHS staffing levels to those seen before 2002.

Layoff notices began arriving as early as 5 a.m. EDT on a Tuesday in 2025, with entire divisions eliminated across multiple agencies, including much of the FDA’s communications and media affairs staff, The Hill reported. The reduction in force was scheduled to take effect on June 30, according to internal notices cited by the publication. StatNews reported on April 1, 2025, that thousands of employees across HHS and its subsidiary agencies received layoff notices, potentially affecting up to 10,000 workers. The report noted that some senior health officials were among those impacted, with the cuts linked to changes under the Trump administration and HHS leadership transitions under Secretary Robert F. Kennedy Jr.

Regarding workforce policies, HHS Instruction 990-3 governs telework, stating that participation is voluntary and subject to management approval based on applicable laws, the nature of the work, and work portability. The instruction references Office of Personnel Management guidance issued on February 3, 2025, allowing HHS to set overall telework levels and exclude certain positions from eligibility. Federal News Network reported that the CDC temporarily paused further telework approvals while clarifying internal policy details, reflecting ongoing adjustments to workforce flexibility.

These developments occur amid evolving federal health policies and agency restructuring efforts, with the CDC’s interim guidance and HHS workforce changes marking significant operational shifts in the nation’s public health infrastructure.